• to decreased the potential risk of severe cardiovascular (heart and blood vessel) issues in Grownups with sort 2 diabetes and cardiovascular disease In Oct 2024, Novo Nordisk printed a research on scientific journal Mother nature a few novel glucose-delicate insulin NNC2215 which will